Literature DB >> 7793127

Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin.

S Tamura1, K Ishihara, K Miyata, C Aizawa, T Kurata.   

Abstract

Cholera toxin B subunit (CTB) (1 microgram) and a trace amount of cholera toxin (CT) (0.1-10 ng), when inoculated intranasally into Balb/c mice together with influenza vaccine, induced synergistically a greater delayed-type hypersensitivity (DTH) response to the vaccine than did a trace amount of CT alone. In parallel with the in vivo response, normal peritoneal macrophages that were incubated in vitro with the vaccine and the CT-containing CTB, induced a higher adenylate cyclase activity and a greater ability to transfer DTH response into naive recipient mice than did the macrophages incubated with the vaccine and CT. The treatment of macrophages with the vaccine and CTB failed to induce either adenylate cyclase or DTH response. From these results, the mechanism by which CTB and a trace amount of CT enhance immune responses synergistically could be explained by the enhancement of the CT action on macrophages or by the efficient binding of a trace amount of CT to antigen-presenting cells in the presence of a relatively large amount of CTB, resulting in enhanced cyclic AMP formation followed by enhanced antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793127     DOI: 10.1016/0264-410x(95)98253-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.

Authors:  C D Partidos; P Vohra; M W Steward
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.

Authors:  Yongxin Zhang; Susan Pacheco; Catherine L Acuna; Kirsten C Switzer; Ying Wang; Xyanthine Gilmore; Gregory R Harriman; Innocent N Mbawuike
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

3.  Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.

Authors:  Takeshi Ichinohe; Izumi Watanabe; Satoshi Ito; Hideki Fujii; Masami Moriyama; Shin-Ichi Tamura; Hidehiro Takahashi; Hirofumi Sawa; Joe Chiba; Takeshi Kurata; Tetsutaro Sata; Hideki Hasegawa
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.

Authors:  Shree R Singh; Vida A Dennis; Christina L Carter; Shreekumar R Pillai; Ayanna Jefferson; Shivendra V Sahi; Eddie G Moore
Journal:  Vaccine       Date:  2007-06-26       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.